EcoDrugPlus

Aldose Reductase-Like

Ensembl ID : ENSLCRG00005021201
Gene Symbol: LOC109138870
3 Cross references
343 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSLCRG00005012012
Gene Symbol: GAA
3 Cross references
234 Possible Orthologues:

Alpha-1a Adrenergic Receptor

Ensembl ID : ENSLCRG00005016724
Gene Symbol: LOC104922698
3 Cross references
191 Possible Orthologues:

Alpha-1b Adrenergic Receptor

Ensembl ID : ENSLCRG00005018530
Gene Symbol: LOC104935312
2 Cross references
194 Possible Orthologues:

Alpha-2b Adrenergic Receptor

Ensembl ID : ENSLCRG00005008072
Gene Symbol: LOC104936827
3 Cross references
149 Possible Orthologues:

Alpha-Synuclein

Ensembl ID : ENSLCRG00005002382
Gene Symbol: LOC104928395
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSLCRG00005009179
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSLCRG00005009552
Gene Symbol: AOC2
3 Cross references
404 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSLCRG00005021835
Gene Symbol: APP
3 Cross references
203 Possible Orthologues:

Amyloid-Beta A4 Protein

Ensembl ID : ENSLCRG00005015547
Gene Symbol: LOC104932346
3 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSLCRG00005023491
Gene Symbol: AR
2 Cross references
213 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSLCRG00005018786
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).